| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |